A solid rebound, very hard stock to accumulate below $2.25, a good div yield, now that should be attractive for some investors, 2019 is a growth year. Champee
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025